SEARCH

SEARCH BY CITATION

REFERENCES

  • Bauer J, Jarre A, Klingmuller D, Elger CE. (2000) Polycystic ovarian syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Research 41(2):163167.
  • Bilo L, Meo R, Nappi C, Annunziato L, Striano S, Colao AM, Merola B, Buscaino GA. (1988) Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29(5):612619.
  • Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. (2001) Characterization of the reproductive endocrine disorders in women with epilepsy. Journal of Clinical Endocrinological Metabolism 86(7):29502956.
  • Breum L, Astrup A, Gram L, Andersen T, Stokholm KH, Christensen NJ, Werdelin L, Madsen J. (1992) Metabolic changes during treatment with valproate in humans: implications for untoward weight gain. Metabolism 41:666670.
  • Corman CL, Leung NM, Guberman AH. (1997) Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Canadian Journal of Neurological Science 24(3):240244.
  • Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianatelli TC, Spina GG, Zapanti ED, Bartzis MI. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinological Metabolism 84:40064011.
  • Dinesen H, Gram L, Anderson T, Dam M. (1984) Weight gain during treatment with valproate. Acta Neurologica Scandanavica 70:6569.
  • Dunaif A, Thomas A. (2001) Current concepts in the polycystic ovarian syndrome. Annual Review of Medicine 52:401419
  • Ferriman D, Gallwey JD. (1961) Clinical assessment of body growth in women. Journal of Clinical Endocrinological Metabolism 21:14401447.
  • Gidal BE, Anderson GD, Spencer NW, Maly MM, Murty J, Pitterle ME, Collins DM, Davis LA. (1996) Valproate-associated weight gain: potential relation to energy expenditure and metabolism in patients with epilepsy. Journal of Epilepsy 9:234241.
  • Herzog AG. (1996) Polycystic ovarian syndrome in women with epilepsy: epileptic or iatrogenic? Annals of Neurology 39:559560.
  • Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. (1986) Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Archives of Neurology 43:341346.
  • Hopkinson ZE, Sattar N, Fleming R, Greer IA. (1998) Polycystic ovarian syndrome: the metabolic syndrome comes to gynecology. British Medical Journal 317:329332
  • Hsueh AJ, Adashi EY, Jones PB, Welsh TH Jr. (1984) Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocrinological Review 5:76127.
  • Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. (1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Annals of Neurology 39(5):579584.
  • Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä W. (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine 329:13831388.
  • Isojärvi JIT, Rätty J, Myllylä VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS. (1998) Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Annals of Neurology 43(4):446451.
  • Isojärvi JIT, Tauboll E, Pakarinen AJ, Van Parys J, Rattya J, Harbo HF, Dale PO, Fauser BC, Gjerstad L, Koivunen R, Knip M, Tapanainen JS. (2001) Altered ovarian function and cardiovascular risk factors in valproate-treated women. American Journal of Medicine 111(4):290296.
  • Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Frank S. (1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clinical Endocrinology (Oxf) 32(2):213230.
  • Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the south-Eastern United States: a prospective study. Journal of Clinical and Endocrinological Metabolism 83:30783082.
  • Lobo RA, Carmina E. (2000) The importance of diagnosing the polycystic ovarian syndrome. Annals of Internal Medicine 132:989993.
  • Lofgren E, Mikkonen K, Tolonen U, Pakarinen A, Koivunen R, Myllyla VV, Tapanainen JS, Isojarvi JI. (2006) Reproductive endocrine function in women with epilepsy: The role of epilepsy type and medication. Epilepsy and Behaviour Nov 10 [Epub ahead of print].
  • Loscher W. (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Progress in Neurobiology 58:3159.
  • McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH. (2003) Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disorders 5:2835.
  • Meirow D, Raz I, Yossepowitch O, Brezenski A, Rosler A, Schenker JG, Berry EM. (1996) dyslipidemia in polycystic ovarian syndrome: different groups, different etiologies? Human Reproduction 11:18481853.
  • Mikkonen K, Vainionpaa LK, Pakarinen AJ, Knip M, Jarvela IY, Tapanainen JS, Isojarvi JIT. (2004) Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 62:445450.
  • Morrell MJ. (1999) Epilepsy in women: the science of why it is special. Neurology 53(S3):S42S48.
  • Mosche SL. (2000) Mechanisms of action of anticonvulsant agents. Neurology 55:S32S40.
  • Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. (1991) Valproate in the treatment of acute mania. A placebo-controlled study. Archives of General Psychiatry 48:6268.
  • O'Donovan C, Kuzumaker V, Graves GR, Bird DC. (2002) Menstrual abnormalities and polycystic ovarian syndrome in women taking valproate for bipolar mood disorder. Journal of Clinical Psychiatry 63:322330.
  • Proposal for revised classification of epilepsies and epileptic syndromes from the Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Epilepsia 30(4):389399.
  • Rasgon NL, Altshuler LL, Gudeman D, Burt VK, Tanavoli S, Hendrick V, Korenman S. (2000) Medication status and polycystic ovarian syndrome in women with bipolar disorder: a preliminary report. Journal of Clinical Psychiatry 61(3):173178.
  • Rasgon NL, Reynolds MF, Elman S, Saad M, Frye MA, Bauer M, Altshuler LL. (2005) Longitudinal evaluation of reproductive function in women treated for bipolar disorder. Journal of Affective Disorders 89:217225.
  • Rättyä J, Pakarinen AJ, Knip M, Repo-Outakoski M, Myllylä VV, Isojärvi JIT. (2001) Early hormonal changes during valproate or carbamezapine treatment: a 3-month study. Neurology 57:440444.
  • Swanson M, Sauerbrei EE, Cooperberg PL. (1981) Medical implications of ultrasonographically detected polycystic ovaries. Journal of Clinical Ultrasound 9:219212.
  • Tanner JM. (1962) Growth at adoloscence. 2nd ed, Blackwell, Oxford.
  • Vainionpăă LK, Rättya J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, Tekay A, Myllylä VV, Isojarvi JIT. (1999) Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology 45(4):444450.
  • Webber MP, Hauser WA, Ottman R, Annegers JF. (1986) Fertility in persons with epilepsy: 1935-1974. Epilepsia 27:746752.
  • W.H.O. special programme of Research, Development and Research training in Human Reproduction, 7 ed. 1983.
  • Zawadski JK, Dunaif A. (1992) Diagnostic criteria for PCOS: towards a rational approach. In DunaifA, GivensJR, HaseltineFP, MerriamGR, (Eds). Polycystic Ovary syndrome. Current Issues in Endocrinology and Metabolism. Blackwell Scientific, Oxford , pp. 377384.